1-Docosanol
| Purity | Grade | Package | Stock | Price | Quantity |
|---|---|---|---|---|---|
| 75% | RG | 25G | In Stock | 7 USD | |
| 75% | RG | 100G | In Stock | 22 USD | |
| 75% | RG | 500G | In Stock | 101 USD | |
| 75% | RG | 2.5KG | In Stock | 494 USD | |
| 75% | RG | 25KG | In Stock | 4915 USD | |
Your region is eligible for ordering. Should you have any questions, please contact us by Email. |
|||||
Promotion
Applications of 661-19-8
1-Docosanol has a variety of applications across different fields:
- Cosmetics: Used as an emollient, emulsifier, and thickener in creams and lotions due to its moisturizing properties.
- Pharmaceuticals: Approved for medical use as an over-the-counter treatment for cold sores under brand names like Abreva.
- Food Industry: Occasionally utilized as a food additive for its emulsifying properties.
- Industrial Uses: Employed in the formulation of surfactants and lubricants.
These applications highlight its versatility as both a cosmetic ingredient and a therapeutic agent .
NMR spectrum of 661-19-8
Safety Information of 661-19-8
Download COA of 661-19-8
Bulk Packaging Price Explanation of 661-19-8
Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.
Purchase Instructions of 661-19-8
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.
